The Potential Role of CDH1 as an Oncogene Combined With Related miRNAs and Their Diagnostic Value in Breast Cancer

BackgroundBreast cancer (BC) is the leading cause of cancer−related mortality in females and the most common malignancy with high morbidity worldwide. It is imperative to develop new biomarkers and therapeutic targets for early diagnosis and effective treatment in BC.MethodsWe revealed the oncogene...

Full description

Bibliographic Details
Main Authors: Dan Xie, Yiyu Chen, Xue Wan, Jingyuan Li, Qin Pei, Yanan Luo, Jinbo Liu, Ting Ye
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.916469/full
_version_ 1831518200646336512
author Dan Xie
Yiyu Chen
Xue Wan
Jingyuan Li
Qin Pei
Yanan Luo
Jinbo Liu
Ting Ye
author_facet Dan Xie
Yiyu Chen
Xue Wan
Jingyuan Li
Qin Pei
Yanan Luo
Jinbo Liu
Ting Ye
author_sort Dan Xie
collection DOAJ
description BackgroundBreast cancer (BC) is the leading cause of cancer−related mortality in females and the most common malignancy with high morbidity worldwide. It is imperative to develop new biomarkers and therapeutic targets for early diagnosis and effective treatment in BC.MethodsWe revealed the oncogene function of cadherin 1 (CDH1) via bioinformatic analysis in BC. Moreover, miRNA database was utilized to predict miRNAs upstream of CDH1. Expression of CDH1-related miRNAs in BC and their values in BC stemness and prognosis were analyzed through TCGA‐BRCA datasets. In addition, Gene Ontology (GO) and Gene Set Enrichment Analysis (GSEA) were performed to explore the potential functions and signaling pathways of CDH1 in combination with CDH1-related miRNAs in BC progression. Finally, the differential expressions of soluble E-cadherin (sE-cad), which is formed by the secretion of CDH1-encoded E-cadherin into serum, analyzed by enzyme-linked immunosorbent assay (ELISA). Reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) was used to detect the expression level of CDH1-related miRNAs in serum samples.ResultsThe mRNA and protein expressions of CDH1 were elevated in BC tissues compared with normal counterparts. Moreover, CDH1 overexpression was positively correlated with BC stage, metastatic, stemness characteristics, and poor prognosis among patients. In predictive analysis, miR-340, miR-185, and miR-20a target CDH1 and are highly expressed in BC. miR-20a overexpression alone was strongly associated with high stemness characteristics and poor prognosis of BC. Additionally, GO, KEGG, and hallmark effect gene set analysis demonstrated that CDH1 in combination with overexpression of miR-340, miR-185, or miR-20a participated in multiple biological processes and underly signaling pathways involving in tumorigenesis and development of BC. Finally, we provide experimental evidence that the combined determination of serum sE-cad and miR-20a in BC has highly diagnostic efficiency.ConclusionsThis study provides evidence for CDH1 as an oncogene in BC and suggests that miR-20a may regulate the stemness characteristics of BC to exert a pro-oncogenic effect by regulating CDH1. Moreover, sE-cad and miR-20a in serum can both be used as valid noninvasive markers for BC diagnosis.
first_indexed 2024-12-12T12:37:39Z
format Article
id doaj.art-7b595c77b7a8422a81f73e3f9fa62d50
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-12-12T12:37:39Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-7b595c77b7a8422a81f73e3f9fa62d502022-12-22T00:24:17ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-06-011310.3389/fendo.2022.916469916469The Potential Role of CDH1 as an Oncogene Combined With Related miRNAs and Their Diagnostic Value in Breast CancerDan XieYiyu ChenXue WanJingyuan LiQin PeiYanan LuoJinbo LiuTing YeBackgroundBreast cancer (BC) is the leading cause of cancer−related mortality in females and the most common malignancy with high morbidity worldwide. It is imperative to develop new biomarkers and therapeutic targets for early diagnosis and effective treatment in BC.MethodsWe revealed the oncogene function of cadherin 1 (CDH1) via bioinformatic analysis in BC. Moreover, miRNA database was utilized to predict miRNAs upstream of CDH1. Expression of CDH1-related miRNAs in BC and their values in BC stemness and prognosis were analyzed through TCGA‐BRCA datasets. In addition, Gene Ontology (GO) and Gene Set Enrichment Analysis (GSEA) were performed to explore the potential functions and signaling pathways of CDH1 in combination with CDH1-related miRNAs in BC progression. Finally, the differential expressions of soluble E-cadherin (sE-cad), which is formed by the secretion of CDH1-encoded E-cadherin into serum, analyzed by enzyme-linked immunosorbent assay (ELISA). Reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) was used to detect the expression level of CDH1-related miRNAs in serum samples.ResultsThe mRNA and protein expressions of CDH1 were elevated in BC tissues compared with normal counterparts. Moreover, CDH1 overexpression was positively correlated with BC stage, metastatic, stemness characteristics, and poor prognosis among patients. In predictive analysis, miR-340, miR-185, and miR-20a target CDH1 and are highly expressed in BC. miR-20a overexpression alone was strongly associated with high stemness characteristics and poor prognosis of BC. Additionally, GO, KEGG, and hallmark effect gene set analysis demonstrated that CDH1 in combination with overexpression of miR-340, miR-185, or miR-20a participated in multiple biological processes and underly signaling pathways involving in tumorigenesis and development of BC. Finally, we provide experimental evidence that the combined determination of serum sE-cad and miR-20a in BC has highly diagnostic efficiency.ConclusionsThis study provides evidence for CDH1 as an oncogene in BC and suggests that miR-20a may regulate the stemness characteristics of BC to exert a pro-oncogenic effect by regulating CDH1. Moreover, sE-cad and miR-20a in serum can both be used as valid noninvasive markers for BC diagnosis.https://www.frontiersin.org/articles/10.3389/fendo.2022.916469/fullCDH1miRNAsoncogenebreast cancerbiomarker
spellingShingle Dan Xie
Yiyu Chen
Xue Wan
Jingyuan Li
Qin Pei
Yanan Luo
Jinbo Liu
Ting Ye
The Potential Role of CDH1 as an Oncogene Combined With Related miRNAs and Their Diagnostic Value in Breast Cancer
Frontiers in Endocrinology
CDH1
miRNAs
oncogene
breast cancer
biomarker
title The Potential Role of CDH1 as an Oncogene Combined With Related miRNAs and Their Diagnostic Value in Breast Cancer
title_full The Potential Role of CDH1 as an Oncogene Combined With Related miRNAs and Their Diagnostic Value in Breast Cancer
title_fullStr The Potential Role of CDH1 as an Oncogene Combined With Related miRNAs and Their Diagnostic Value in Breast Cancer
title_full_unstemmed The Potential Role of CDH1 as an Oncogene Combined With Related miRNAs and Their Diagnostic Value in Breast Cancer
title_short The Potential Role of CDH1 as an Oncogene Combined With Related miRNAs and Their Diagnostic Value in Breast Cancer
title_sort potential role of cdh1 as an oncogene combined with related mirnas and their diagnostic value in breast cancer
topic CDH1
miRNAs
oncogene
breast cancer
biomarker
url https://www.frontiersin.org/articles/10.3389/fendo.2022.916469/full
work_keys_str_mv AT danxie thepotentialroleofcdh1asanoncogenecombinedwithrelatedmirnasandtheirdiagnosticvalueinbreastcancer
AT yiyuchen thepotentialroleofcdh1asanoncogenecombinedwithrelatedmirnasandtheirdiagnosticvalueinbreastcancer
AT xuewan thepotentialroleofcdh1asanoncogenecombinedwithrelatedmirnasandtheirdiagnosticvalueinbreastcancer
AT jingyuanli thepotentialroleofcdh1asanoncogenecombinedwithrelatedmirnasandtheirdiagnosticvalueinbreastcancer
AT qinpei thepotentialroleofcdh1asanoncogenecombinedwithrelatedmirnasandtheirdiagnosticvalueinbreastcancer
AT yananluo thepotentialroleofcdh1asanoncogenecombinedwithrelatedmirnasandtheirdiagnosticvalueinbreastcancer
AT jinboliu thepotentialroleofcdh1asanoncogenecombinedwithrelatedmirnasandtheirdiagnosticvalueinbreastcancer
AT tingye thepotentialroleofcdh1asanoncogenecombinedwithrelatedmirnasandtheirdiagnosticvalueinbreastcancer
AT danxie potentialroleofcdh1asanoncogenecombinedwithrelatedmirnasandtheirdiagnosticvalueinbreastcancer
AT yiyuchen potentialroleofcdh1asanoncogenecombinedwithrelatedmirnasandtheirdiagnosticvalueinbreastcancer
AT xuewan potentialroleofcdh1asanoncogenecombinedwithrelatedmirnasandtheirdiagnosticvalueinbreastcancer
AT jingyuanli potentialroleofcdh1asanoncogenecombinedwithrelatedmirnasandtheirdiagnosticvalueinbreastcancer
AT qinpei potentialroleofcdh1asanoncogenecombinedwithrelatedmirnasandtheirdiagnosticvalueinbreastcancer
AT yananluo potentialroleofcdh1asanoncogenecombinedwithrelatedmirnasandtheirdiagnosticvalueinbreastcancer
AT jinboliu potentialroleofcdh1asanoncogenecombinedwithrelatedmirnasandtheirdiagnosticvalueinbreastcancer
AT tingye potentialroleofcdh1asanoncogenecombinedwithrelatedmirnasandtheirdiagnosticvalueinbreastcancer